These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20332278)

  • 21. High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium.
    Abubakar M; Howat WJ; Daley F; Zabaglo L; McDuffus LA; Blows F; Coulson P; Raza Ali H; Benitez J; Milne R; Brenner H; Stegmaier C; Mannermaa A; Chang-Claude J; Rudolph A; Sinn P; Couch FJ; Tollenaar RA; Devilee P; Figueroa J; Sherman ME; Lissowska J; Hewitt S; Eccles D; Hooning MJ; Hollestelle A; Wm Martens J; Hm van Deurzen C; ; Bolla MK; Wang Q; Jones M; Schoemaker M; Broeks A; van Leeuwen FE; Van't Veer L; Swerdlow AJ; Orr N; Dowsett M; Easton D; Schmidt MK; Pharoah PD; Garcia-Closas M
    J Pathol Clin Res; 2016 Jul; 2(3):138-53. PubMed ID: 27499923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis.
    Sun H; Kang EY; Chen H; Sweeney KJ; Suchko M; Wu Y; Wen J; Krishnamurthy S; Albarracin CT; Ding QQ; Foo WC; Sahin AA
    Breast Cancer Res Treat; 2024 Jun; 205(2):403-411. PubMed ID: 38441847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on breast carcinoma Her2/neu and hormonal receptors status assessed by automated images analysis systems: ACIS III (Dako) and ScanScope (Aperio).
    Słodkowska J; Filas V; Buszkiewicz E; Trzeciak P; Wojciechowski M; Koktysz R; Staniszewski W; Breborowicz J; Rojo MG
    Folia Histochem Cytobiol; 2010 Jan; 48(1):19-25. PubMed ID: 20529811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual-energy CT quantitative parameters for evaluating Immunohistochemical biomarkers of invasive breast cancer.
    Wang X; Liu D; Zeng X; Jiang S; Li L; Yu T; Zhang J
    Cancer Imaging; 2021 Jan; 21(1):4. PubMed ID: 33413654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
    Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M
    BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proficiency testing of immunohistochemical biomarker assays in breast cancer.
    Wasielewski Rv; Hasselmann S; Rüschoff J; Fisseler-Eckhoff A; Kreipe H
    Virchows Arch; 2008 Dec; 453(6):537-43. PubMed ID: 18958494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative analysis of estrogen receptor heterogeneity in breast cancer.
    Chung GG; Zerkowski MP; Ghosh S; Camp RL; Rimm DL
    Lab Invest; 2007 Jul; 87(7):662-9. PubMed ID: 17334408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computer Aided Semi-Automated Evaluation of HER2 Immunodetection--A Robust Solution for Supporting the Accuracy of Anti HER2 Therapy.
    Micsik T; Kiszler G; Szabó D; Krecsák L; Hegedűs C; Tibor K; Molnár B
    Pathol Oncol Res; 2015 Sep; 21(4):1005-11. PubMed ID: 25788005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of tissue decalcification on the quantification of breast cancer biomarkers by digital image analysis.
    Gertych A; Mohan S; Maclary S; Mohanty S; Wawrowsky K; Mirocha J; Balzer B; Knudsen BS
    Diagn Pathol; 2014 Nov; 9():213. PubMed ID: 25421113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.
    Marotti JD; Collins LC; Hu R; Tamimi RM
    Mod Pathol; 2010 Feb; 23(2):197-204. PubMed ID: 19898422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of automated image analysis in evaluation of Mesothelioma Tissue Microarray (TMA) from National Mesothelioma Virtual Bank.
    Amin W; Srinivasan M; Song SY; Parwani AV; Becich MJ
    Pathol Res Pract; 2014 Feb; 210(2):79-82. PubMed ID: 24359722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data.
    Laurinavicius A; Laurinaviciene A; Ostapenko V; Dasevicius D; Jarmalaite S; Lazutka J
    Diagn Pathol; 2012 Mar; 7():27. PubMed ID: 22424533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free digital image analysis software helps to resolve equivocal scores in HER2 immunohistochemistry.
    Helin HO; Tuominen VJ; Ylinen O; Helin HJ; Isola J
    Virchows Arch; 2016 Feb; 468(2):191-8. PubMed ID: 26493985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer.
    Wesseling J; Tinterri C; Sapino A; Zanconati F; Lutke-Holzik M; Nguyen B; Deck KB; Querzoli P; Perin T; Giardina C; Seitz G; Guinebretière JM; Barone J; Dekker L; de Snoo F; Stork-Sloots L; Roepman P; Watanabe T; Cusumano P
    Virchows Arch; 2016 Sep; 469(3):297-304. PubMed ID: 27377889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.
    Rexhepaj E; Brennan DJ; Holloway P; Kay EW; McCann AH; Landberg G; Duffy MJ; Jirstrom K; Gallagher WM
    Breast Cancer Res; 2008; 10(5):R89. PubMed ID: 18947395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soy consumption and histopathologic markers in breast tissue using tissue microarrays.
    Maskarinec G; Erber E; Verheus M; Hernandez BY; Killeen J; Cashin S; Cline JM
    Nutr Cancer; 2009; 61(5):708-16. PubMed ID: 19838945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemistry scoring of breast tumor tissue microarrays: A comparison study across three software applications.
    Baker GM; Bret-Mounet VC; Wang T; Veta M; Zheng H; Collins LC; Eliassen AH; Tamimi RM; Heng YJ
    J Pathol Inform; 2022; 13():100118. PubMed ID: 36268097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Image cytometric validation of breast carcinoma markers (ER, HER2 and MIB-1) using tissue microarrays: rabbit monoclonal vs. FDA-approved antibodies.
    Nassar A; Norton CM; Lawson D; Cohen C
    Anal Quant Cytol Histol; 2010 Aug; 32(4):192-200. PubMed ID: 21434519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer.
    Rimm DL; Leung SCY; McShane LM; Bai Y; Bane AL; Bartlett JMS; Bayani J; Chang MC; Dean M; Denkert C; Enwere EK; Galderisi C; Gholap A; Hugh JC; Jadhav A; Kornaga EN; Laurinavicius A; Levenson R; Lima J; Miller K; Pantanowitz L; Piper T; Ruan J; Srinivasan M; Virk S; Wu Y; Yang H; Hayes DF; Nielsen TO; Dowsett M
    Mod Pathol; 2019 Jan; 32(1):59-69. PubMed ID: 30143750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ER and PR immunohistochemistry and HER2 FISH versus oncotype DX: implications for breast cancer treatment.
    Park MM; Ebel JJ; Zhao W; Zynger DL
    Breast J; 2014; 20(1):37-45. PubMed ID: 24261318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.